INIVATA IS A LEADER

IN LIQUID BIOPSY

Unlocking essential genomic information from a simple blood draw to transform the care of cancer patients

proudly supporting

Lung Cancer Awareness Month

Our Technology

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

Our Solutions

Our US Medicare-reimbursed lead product InVisionFirst-Lung is already transforming the lives of advanced NSCLC patients

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

Find out More

Partnerships

Our Technology

Contact Us

Latest News and Events

Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study

29 Oct 2019

Inivata to provide ctDNA liquid biopsy using its InVisionFirst®-Lung test to analyze resistance in patients treated with lorlatinib ... Read More

More News

Clinical Utility of ctDNA Driver Genomic Alterations (GA) Directing Targeted Therapy in Untreated Advanced NSCLC Patients

14 Oct 2019

L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, A.-M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. ... Read More

More Publications
ESMO Asia Congress 2019

ESMO Asia Congress 2019

Event expiration date display - 22 - 24 NOV 2019

Location: Singapore Read More

More Events

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives. 

This is the story of the first patient Inivata tested.

Find out More

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

See our latest open roles

 @inivata

Retweet on TwitterInivata Retweeted
November 20, 2019

Alabama has one of the highest incidences of LC and has the worst 5 year survival of all states. Only average with LC screening rate. More women die of LC in Alabama than men. We owe our people better care. #LCSM #lcam https://twitter.com/DevikaDasMD/status/1196940119246286848

Retweet on TwitterInivata Retweeted
November 19, 2019

I am super excited to attend the LIFESTARS award 2019 as a part of @Inivata in Central London. We have been shortlisted for the awards two categories !!! Well done!!!
#lifestarsawards #London #inivata #lifesciences #biotech #Cambridge
🤞Good luck Inivata!!

November 19, 2019

Clive Morris on what’s next for Inivata and our #liquidbiopsy technology - read more in our new blog here https://tinyurl.com/uflbxre #LCAM #LCSM #NSCLC